Moderna to advance two Omicron vaccine candidates against newer variants
Moderna said its decision to develop the bivalent vaccines was based on different market preferences for shots against the…
Author
Sanofi launches health brand with non-profit treatments for low-income countries
The treatments will be provided under the new Impact brand, part of Sanofi’s global health unit launched last year, which sits…
Novavax expects COVID vaccine targetting Omicron in fourth quarter
The company's vaccine, based on an earlier strain of the virus, has not yet been authorised in the US, and is currently under FDA…
Oxford Biomedica signs new deal to make AstraZeneca COVID shot
Under the expanded deal, AstraZeneca will have access to Oxford Biomedica’s Oxbox manufacturing facility to produce its shot on an…
China’s Clover says its COVID booster shot candidate lifts antibody against Omicron
The booster shot also elicited a 12-fold rise in the neutralising antibody level against the BA.1 subvariant, the company said,…
AstraZeneca gets EU backing for targetted breast cancer therapies
The drug, which has received a similar recommendation in the US in March, is a key asset for AstraZeneca
Promising hep B data helps GSK inch closer to functional cure
If the results are reinforced in later-stage trials, the British drugmaker has estimated the drug could generate peak sales of…
Sanofi, GSK COVID-19 vaccine found effective against Omicron
The vaccine targets the beta variant – first identified in South Africa – as well as the original Wuhan strain of the virus
Smallpox drugmakers get new orders as monkeypox spreads
More than 3,000 confirmed cases of monkeypox have been reported from 40 countries where the disease is not endemic
Moderna to build new vaccine facility in Britain
Britain's health ministry said that the pandemic had shown mRNA technology as one of the fastest routes to develop new vaccines,…